These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37722607)

  • 1. Glyoxalase I is a novel target for the prevention of metabolic derangement.
    Miranda ER; Haus JM
    Pharmacol Ther; 2023 Oct; 250():108524. PubMed ID: 37722607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
    Rabbani N; Thornalley PJ
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyoxalase 1 Modulation in Obesity and Diabetes.
    Rabbani N; Thornalley PJ
    Antioxid Redox Signal; 2019 Jan; 30(3):354-374. PubMed ID: 29160087
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments.
    Rabbani N; Xue M; Thornalley PJ
    Clin Sci (Lond); 2016 Oct; 130(19):1677-96. PubMed ID: 27555612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicarbonyl Stress and Glyoxalase-1 in Skeletal Muscle: Implications for Insulin Resistance and Type 2 Diabetes.
    Mey JT; Haus JM
    Front Cardiovasc Med; 2018; 5():117. PubMed ID: 30250846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylglyoxal and glyoxalase 1-a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes.
    Rabbani N
    Clin Sci (Lond); 2022 Jun; 136(11):819-824. PubMed ID: 35635155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of Non-Pathological Liver Fat Is Associated with the Loss of Glyoxalase I Activity in Humans.
    Peter A; Schleicher E; Kliemank E; Szendroedi J; Königsrainer A; Häring HU; Nawroth PP; Fleming T
    Metabolites; 2024 Apr; 14(4):. PubMed ID: 38668337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicarbonyl stress in clinical obesity.
    Masania J; Malczewska-Malec M; Razny U; Goralska J; Zdzienicka A; Kiec-Wilk B; Gruca A; Stancel-Mozwillo J; Dembinska-Kiec A; Rabbani N; Thornalley PJ
    Glycoconj J; 2016 Aug; 33(4):581-9. PubMed ID: 27338619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of NAMPT and SIRT2 but not SIRT1 attenuate GLO1 expression and activity in human skeletal muscle.
    Miranda ER; Varshney P; Mazo CE; Shadiow J; Ludlow AT; Haus JM
    Redox Biol; 2024 Sep; 75():103300. PubMed ID: 39142179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Levels of the Reactive Metabolite Methylglyoxal Recapitulate Progression of Type 2 Diabetes.
    Moraru A; Wiederstein J; Pfaff D; Fleming T; Miller AK; Nawroth P; Teleman AA
    Cell Metab; 2018 Apr; 27(4):926-934.e8. PubMed ID: 29551588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of putative glyoxalase 1-deficient mouse and dicarbonyl stress on embryonic stem cells in vitro.
    Shafie A; Xue M; Barker G; Zehnder D; Thornalley PJ; Rabbani N
    Biochem J; 2016 Nov; 473(22):4255-4270. PubMed ID: 27671893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of the
    Šilhavý J; Malínská H; Hüttl M; Marková I; Oliyarnyk O; Mlejnek P; Šimáková M; Liška F; Kazdová L; Moravcová R; Novotný J; Pravenec M
    Antioxidants (Basel); 2020 Nov; 9(12):. PubMed ID: 33255888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicarbonyl stress and glyoxalase enzyme system regulation in human skeletal muscle.
    Mey JT; Blackburn BK; Miranda ER; Chaves AB; Briller J; Bonini MG; Haus JM
    Am J Physiol Regul Integr Comp Physiol; 2018 Feb; 314(2):R181-R190. PubMed ID: 29046313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators.
    He Y; Zhou C; Huang M; Tang C; Liu X; Yue Y; Diao Q; Zheng Z; Liu D
    Biomed Pharmacother; 2020 Nov; 131():110663. PubMed ID: 32858501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Rabbani N; Thornalley PJ
    Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity, regulation, copy number and function in the glyoxalase system.
    Rabbani N; Xue M; Thornalley PJ
    Biochem Soc Trans; 2014 Apr; 42(2):419-24. PubMed ID: 24646254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylglyoxal-Glyoxalase 1 Balance: The Root of Vascular Damage.
    Nigro C; Leone A; Raciti GA; Longo M; Mirra P; Formisano P; Beguinot F; Miele C
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicarbonyl-mediated AGEing and diabetic kidney disease.
    Dimitropoulos A; Rosado CJ; Thomas MC
    J Nephrol; 2020 Oct; 33(5):909-915. PubMed ID: 32170575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyoxalase in diabetes, obesity and related disorders.
    Rabbani N; Thornalley PJ
    Semin Cell Dev Biol; 2011 May; 22(3):309-17. PubMed ID: 21335095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.